Lars Fruergaard Jørgensen has been with Novo Nordisk since 1991 and was appointed president and chief executive officer of Novo Nordisk in January 2017.

Lars Fruergaard Jørgensen has, over the years, held several leadership positions, including postings in the Netherlands, the US and Japan. He was appointed senior vice president for IT & Corporate Development in 2004. In 2013, he was appointed executive vice president and chief information officer, assuming IT, Quality & Corporate Development responsibility. In 2014, he also took on Corporate People & Organisation and Business Assurance responsibilities and became chief of staff.

Lars Fruergaard Jørgensen is President of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and is a member of the Board of Directors at Danmarks Nationalbank (the Danish central bank).

Lars Fruergaard Jørgensen has an MSc in Finance and Business Administration from Aarhus School of Business, Aarhus University, Denmark.